Elite Health Systems Inc.

What they do

The company operates through two wholly owned subsidiaries: Elite Health Plan, Inc., which designs, markets and manages a Medicare Advantage (Medicare Part C) plan regulated by CMS, and Physician Support Systems Inc. (PSS), acquired in November 2025, which provides healthcare management services to medical practices. Elite Health Plan has operated a Medicare Advantage plan in Los Angeles, Riverside and San Bernardino counties since January 2026, serving Medicare-eligible seniors. Management describes its model as a coordinated care delivery approach intended to improve clinical outcomes and lower total cost of care.

Revenue drivers

• Medicare Advantage policy revenue (Elite Health Plan) — Premiums from Medicare Advantage members in three California counties; recorded $334,000 for the six months ended June 30, 2026 and $162,000 in Q2 2026 alone. Policy expenses of $387,000 for the six months exceeded the related revenue. The plan only began operating January 1, 2026.
• Services revenue (Physician Support Systems) — Employee leasing and consulting services billed to health clinic customers; $2,707,000 for the six months ended June 30, 2026 with cost of revenue of $1,140,000. In 2025, this line produced $1,024,000 for the two months following the November 2025 acquisition, at cost of $906,000.
• Planned C-SNP specialized plans — Application filed with CMS in February 2026 for 2027 Chronic Condition Special Needs Plans targeting congestive heart failure, diabetes mellitus and cardiovascular disease. No revenue or approval has been reported for this line.

Recent performance

Q2 2026 revenue was $1,310,000 from services plus $162,000 of policy revenue, against cost of revenue of $496,000 and policy expenses of $183,000, but SG&A of $1,709,000 drove a net loss of $1,532,000 versus a $441,000 loss a year earlier. For the six months ended June 30, 2026, revenue was $3,041,000 (services $2,707,000, policy $334,000), SG&A was $3,124,000, and the net loss was $2,826,000. Operating cash use was $2,609,000 for the six months, and the company raised only $153,000 of proceeds in that period versus $5,800,000 in the first half of 2025. As of June 30, 2026: total assets $3.9M, total liabilities $1.3M, equity $2.6M, cash $1.3M. Accumulated deficit was $15,075,000 at June 30, 2026, up from $12,249,000 at December 31, 2025.

Strategy

The stated priority is building a managed care organization around Elite Health Plan and expanding the Medicare Advantage footprint, whether into additional California counties, new states, or specialized products such as C-SNP plans. Management applied to CMS in February 2026 for 2027 C-SNP plans covering congestive heart failure, diabetes and cardiovascular disease. It also says it may pursue acquisitions of physician groups and management service organizations and partnerships with physician organizations, health systems and technology companies. Capital raised in private placements — $4.8 million in 2024, $3.7 million in 2025 and only $153,000 in the first half of 2026 — is intended to fund this buildout.

Risks

• Going concern and funding need — The 10-K states that an accumulated deficit of $12,249,000, $3,758,000 of cash, no credit line and no other readily available capital raised substantial doubt about continuing as a going concern at December 31, 2025, and the company expects to keep reporting operating losses well beyond 2026.
• Unprofitable Medicare Advantage launch — Policy expenses of $387,000 exceeded policy revenue of $334,000 in the first half of 2026, and management ties the larger net loss mainly to investment in Elite Health Plan exceeding revenue generated.
• Regulatory and reimbursement dependence — Elite Health Plan depends on CMS approval, state licensure and CMS payment rates; the company cites CMS's CY 2027 Advance Notice projecting a near-flat net average payment update of roughly 0.09%.
• Reliance on private placements and thin capital raise — Operations have been funded through private placements of common stock, with only $153,000 raised in the six months ended June 30, 2026, compared with $5,800,000 in the prior-year period, while cash use was $2,609,000.

Outlook

Management says it believes its plan alleviates the going concern doubt and that it will be able to continue as a going concern through at least the next twelve months, contingent on raising additional capital that it expects to access through 2026. It has stated that it will continue to report operating losses for a significant time beyond the end of 2026. The company's next stated milestones are geographic Medicare Advantage expansion and the 2027 C-SNP application filed with CMS in February 2026, subject to approval.